ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Addiction · Drug Alcohol Depend · 2026-07-28

Systematic review of 11 RCTs (9 meta-analysed): with non-titratable NRT, normal/fast nicotine metabolisers had lower odds of verified quitting than slow metabolisers (OR 0.81, 95% CI 0.68–0.96); no significant difference with titratable NRT, bupropion or varenicline.

Meta-analysisn = 11 trials
Xie et al. Role of nicotine metabolite ratio in pharmacological interventions on smoking cessation: A systematic review and meta-analyses of randomized controlled trials
Addiction · J Subst Use Addict Treat · 2026-01-18

In a secondary analysis of 97 opioid-using participants with HIV in the St PETER HIV trial, nicotinic partial agonists (varenicline, cytisine) vs nicotine replacement therapy did not significantly change self-reported opioid use at 1, 3, 6 or 12 months.

Secondary analysisn = 97
Rich et al. Assessing the impact of nicotinic partial agonists compared to NRT on opioid and cigarette use: A secondary analysis investigating treatment outcomes for co-occurring nicotine and opioid use

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.